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Effect of Short-Term Interval Training on Fatigue, Depression and Fitness in 
Normal Weight vs. Overweight person with Multiple Sclerosis 
 
Abstract 
Context: Excessive weight is a health problem that can exacerbate multiple sclerosis (MS) 
symptoms and its associated comorbidities such as depression and fatigue. In addition, weight 
may be a moderator of exercise effects on depression and fatigue symptoms. 
Objective: This study aimed to investigate the effects of exercise training on fatigue and 
depression in normal and overweight individuals with MS.  
Methods: Sixty-six persons with MS were randomly assigned into an exercise or control 
condition based on body weight status (overweight vs. normal-weight). The exercise conditions 
involved 8-weeks of interval exercise at 60-75% Wattpeak, while the control condition did not 
involve any exercise. Fatigue, depression, aerobic capacity, time up and go (TUG) and body 
mass index were measured before and following the 8-week period.  
Results: There were no significant relationship’s revealed for weight status interactions for any 
of the variables examined. There were significant condition main effects for fatigue, depression, 
aerobic capacity and TUG, and significant improvements were noted for the exercise conditions, 
but not in the non-exercising control group.  
Conclusion: The results from this study confirm that exercise is an effective therapeutic 
intervention for improving fatigue, depression and functional parameters, independent of initial 
weight status, in persons with MS.  
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INTRODUCTION 
 
Fatigue and depression are two of the most common, debilitating, and poorly managed 
symptoms in persons with multiple sclerosis (MS) [1]. Cohort studies conducted on prevalence 
and incidence of fatigue in MS indicate that more than 50% of persons with MS experience 
symptoms of fatigue at least once a week [2, 3]. The prevalence of depression ranges between 10 
and 54% among persons with MS [1, 3-5] and this is two to three times higher than healthy 
individuals and those with other chronic diseases [4]. A recent systemic review and meta-
analysis of 58 studies with a total sample size of 87,756 persons with MS reported a prevalence 
of depression exceeding 30% [5]. Fatigue and depression symptoms are further related to the 
most commonly prescribed immune-modulatory medications in MS (i.e., interferon-beta) [3, 6]. 
Fatigue and depression are commonly accompanied by disability progression [2, 7], and fatigue 
and depression symptoms may reduce physical activity and quality of life in persons with MS 
[7]. The prevalence and impact of fatigue and depression underscore the importance of managing 
these symptoms in persons with MS [8, 9]. To date, pharmacological and psychological 
interventions have had limited positive effects in reducing fatigue symptoms and depression 
[10]. This supports the rationale for considering other behavioral strategies for reducing fatigue 
and depression in persons with MS.  
There is a growing body of evidence indicating that physical activity is an effective 
strategy for reducing fatigue and depression in clinical populations including person with MS [2, 
9, 11]. Indeed, a meta-analysis of 17 studies reported the positive effects of exercise training on 
fatigue in persons with MS (effect size=0.45, standard error= 0.12, 95% CI = 0.22-0.68) [2]. A 
further meta-analysis of 13 studies reported that exercise training improved depressive symptoms 
among persons with MS (effect size=0.36, standard error= 0.09, 95% CI = 0.18-0.54) [7]. Both 
meta-analyses confirmed the positive effects of exercise on fatigue and depression in persons 
with MS, but the effect sizes were modest and heterogeneous, and support further research for 
factors that moderate the effects of exercise training.  
There are several factors that may moderate the beneficial effect of exercise training on 
fatigue and depression in persons with MS. Body composition and weight status may be one of 
the most salient moderating factors. Weight gain is a major public health concern that increases 
the risk of MS [12]. Previous studies clearly report a high prevalence of overweight and obesity 
in persons with MS indicating that more than 40% of  persons with MS were overweight and 
nearly half were obese [13, 14]. Overweight and obese individuals frequently report experiencing 
fatigue and depression more frequently than people of normal weight [15]. Body weight is 
further associated with a decrease in walking ability and aerobic capacity in persons with MS 
[16]. The theory that weight can be a moderating factor for exercise effect has been outlined in 
previous research[17, 18]. These studies confirm the role of initial weight and weight loss on 
adaptation following an exercise program intervention. Even when no significant weight loss has 
been observed, this moderating weight effect has been investigated in cardiovascular disease and 
aerobic fitness[17], walking ability[17], and psychological parameters [18]. Collectively, body 
weight can be considered as an important and influential moderator of exercise training, but the 
moderating role of weight has not been investigated in persons with MS.  
The present study examined the hypothesis that body weight may be a moderator of exercise 
training effects on the outcomes of fatigue and depression, based on individual adaptations in 
aerobic capacity, in person with MS. We further examined the likelihood of a link between 
functional changes in fatigue and depression in overweight and normal weight persons with MS. 
 METHODS 
Study design and procedure  
 
This study was a randomized controlled trial with a blinded outcome assessment.  The study was 
approved by the Ethics Committee of Abadan University, Abadan, Iran, but and did not have a 
clinical trials registration. All participants gave written informed consent prior to commencement 
of the study. The consolidated standards of reporting trial (CONSORT) diagram describing 
participant interaction during the study is presented in Fig. 1. An invitation letter was sent to all 
persons with relapsing-remitting MS (RRMS) that were registered at the MS center of Khuzestan 
(Iran). We screened 108 volunteers diagnosed with RRMS for inclusion based on the following 
criteria; a) RRMS type (revised McDonald criteria [19]), b) general body mass index (BMI) 
ranging between 20 to 30 kg/m2, c) 0 < Expanded Disability Status Scale (EDSS) ≤ 4, and d) age 
> 22 years. There were 103 RRMS participants who were eligible to participate in the study 
based on exclusion criteria (54 normal weight and 49 overweight persons with MS). The 
exclusion criteria were as follows: a) those engaged in regular moderate to heavy exercise during 
the study or activity within the previous year; b) smoking; c) documented relapses or acute 
multiple sclerosis exacerbation during the study or within the last six months; d) volunteers with 
orthopedic limitations; or e) presence of chronic diseases (i.e. kidney disease) other than MS. 
We randomly selected 66 RRMS person (33 normal weight and 33 overweight persons 
with MS) from 103 eligible MS participants to participate in the current study (Fig. 1).  
All measures including fatigue, depression, time up and go test (TUG), aerobic capacity and 
body composition (weight, BMI) were measured prior to starting the intervention and were 
repeated post intervention. Fatigue, depression, aerobic capacity and BMI were assessed by 
authors (RN and MM); EDSS scores were determined by a neurologist (NM). 
 
Randomization and masking 
 
A concealed randomization procedure was carried out by classifying participants based on initial 
BMI.  Sixty-six RRMS participants were then randomly selected and assigned into two 
conditions (exercise or control condition). BMI was calculated from body mass (kg, Seca515, 
Sweden) divided by the square of height (m) of an individual. Therefore, normal weight and 
overweight participants are referred to as participants with 20 kg/m2<BMI<25 kg/m2 and 25 
kg/m2<BMI< 30 kg/m2, respectively. Based on BMI measures, each group was divided into two 
sub-groups, which yielded four groups including overweight control (OC, n=15), overweight 
exercise (OE, n=18), normal weight controls (NC, n=15), and normal exercise (NE, n=18) 
groups. During the study, 5 participants withdrew due to a relapse (1 participant from NE) and 
reluctance to continue the program (4 participants).  
 
Primary end point 
Fatigue  
 
The fatigue severity scale (FSS) measured the primary end point of fatigue. The FSS has 
captured the effects of exercise on fatigue in previous studies involving persons with MS [2] and 
the reliability and validity of the Persian version of FSS has been established previously [20]. 
The questionnaire consists of 9 questions; each question is rated on a scale from 1 (representing 
minimal fatigue) to 7 (representing maximal fatigue). The overall FSS score consists of an 
average of the 9 items and assesses the severity of fatigue on a scale between 1 and 7 in persons 
with MS [2, 20].  
 
Depression 
 
The Beck depression inventory (BDI) measured the primary end point of depression severity. 
The BDI has been widely used as a valid psychometric test of depression status in previous MS 
studies [21] and the reliability and validity of the Persian version of BDI has been established 
previously[22]. The BDI is a 21-item question tool (each question ranging between 0 and 3), and 
overall scores ranged between 0 (represents minimal depression) and 63 (represents maximal 
depression) [7]. 
 
Secondary end point 
Timed up and go 
 
The TUG was administered as a measure of mobility [23]. The TUG test requires both static and 
dynamic balance ability. Participants on hearing the command go, raise from a seated position 
and walk 3 meters forward, turn and walk back and sit in a chair [23]. The investigator then 
records the TUG test time in seconds.   
 
Exercise program and aerobic capacity test 
 
The exercise program for both exercise groups consisted of 8 weeks (3 days per week) of upper- 
and lower-limb cycling (Monark 891E and 894E ergometers, Sweden). The exercise program 
was administered in the exercise physiology lab under the supervision of exercise physiologists 
(RN and MM). The interval exercise program was chosen because it (1) has been demonstrated 
to be well tolerated by persons with MS [24, 25], (2) has many benefits [25-27], and (3) includes 
intervals of rest and exercise that are suitable for person with MS who have fatigue [25]. 
Exercise sessions started with a warm up (10 min) and finished with cool down (10 min). The 
main body of the exercise program in the first week consisted of three intervals (two min) 
cycling separately for upper- and lower-limbs. Following exercise, there were two min of 
inactive rest between intervals. The number of intervals gradually increased progressively over 
the course of the 8 week period. This concluded in participants undertaking six intervals 
separately for the upper and lower limbs in week 8. The training intensity was adjusted by watt 
peak (Wpeak) determined by the aerobic capacity (Vo2peak) test [28, 29]. Training intensity started 
at 60% Wpeak (percent peak work rate) during week 1 and increased gradually to 75% Wpeak in 
week 8. During all sessions, the pedal rate was fixed at 50 rpm. The session duration was 42 min 
in week 1 and increased gradually to 66 min in week 8. During the intervention program, the 
control groups only completed pre and post outcome assessments and did not participate in any 
additional exercise program. The exercise program used has been previously studied in MS 
patients, and reports indicate that the exercise program was well-tolerated [24, 25]. 
 
Statistical analysis 
 
To test our hypothesis, we used a two-factor ANOVA (weight status: 2 levels of normal weight 
or overweight, condition: 2 levels of exercise or control) (SPSS Statistics 21®, IBM®, Armonk, 
NY, USA) on change scores computed on the difference between pre- and post-test scores. We 
reported partial eta squared (ηp2) for documenting the effect size associated with the ANOVA 
tests. Pearson correlation coefficients were used to determine the relationship between changes 
in Vo2peak fatigue, depression and TUG. Significance was defined at p value <0.05. 
 
RESULTS 
 
Of the 66 RRMS participants, 61 completed the current study, with a completion rate of 92.4%. 
Reasons for drop-out are listed in Fig. 1. The exercise program was well tolerated by both 
overweight and normal-weight persons with MS, and no adverse events were reported by study 
participants or personal (i.e., stroke, illness, low back pain, knee pain, fall and etc.). The exercise 
program was well attended by both exercise groups. Of the 24 exercise sessions, overweight and 
normal weight participants attended 22.2±1.9 and 22±1.6 sessions, respectively. This reflects 
92.5 and 91.7 percent compliance with the exercise sessions. 
 
Baseline results 
 
Results indicated main effects of weight status on baseline values of fatigue (p=0.045, F=4.2), 
TUG (p=0.042, F=4.34) and Vo2peak (p=0.020, F=5.73). Vo2peak was significantly higher, whereas 
TUG and fatigue were significantly lower in normal weight than overweight groups at baseline. 
Weight (p=0.001, F=271.72) and BMI (p=0.001, F=400.10) were significantly higher in 
overweight groups at baseline. There were no differences in depression between groups at 
baseline (p>0.05, table 1).  
 
Primary endpoint results 
 
There were no significant interactions between weight status and condition on any of the primary 
endpoints (p>0.05). There were significant main effects of condition on fatigue (F=12.7, 
p=0.001, ηp2= 0.18) and depression (F=8.69, p=0.005, ηp2= 0.13). The exercise conditions had 
statistically significant improvements for fatigue and depression, whereas the control showed no 
significant changes (Fig. 2). 
 
Secondary endpoint results 
 
We observed the absence of significant interaction effects for Vo2peak (F=1.89, p=0.17) and TUG 
(F=0.40, p=0.52). There were significant conditions main effects on Vo2peak (F=21.06, p=0.001, 
ηp2= 0.27) and TUG (F=11.57, p=0.001, ηp2=0.17). Those in the exercise condition had 
significant improvements in aerobic capacity and walking performance, whereas the control did 
not (Fig. 2). There was neither a significant interaction (F=0.78, p=0.38) nor main effects 
(p>0.05) for change in BMI.  
 
Correlation 
 
Pearson correlations (scatterplots in Fig. 3) indicated a significant negative correlation between 
changes in Vo2peak and changes in fatigue (r=-0.59), depression (r=-0.50) and TUG (r=-0.31, 
p<0.05) across all participants. The change in Vo2peak within the exercise condition had a 
stronger negative correlation with changes in fatigue (r=-0.62), depression (r=-0.54) and TUG 
(r=-0.46, p<0.05). 
 
DISCUSSION 
 
This is the first randomized controlled trial comparing the effects of interval training involving 
lower and upper body cycling exercise at moderate-intensity on fatigue, depression and 
functional parameters in persons with MS while considering weight as a moderating factor. Our 
results indicate that overweight and normal weight persons with MS had similar benefits from 
the exercise program for fatigue and depression as well as Vo2peak and TUG; however, 
overweight participants had a poorer status at baseline for fatigue and Vo2peak. There was a clear 
relationship between changes in aerobic capacity with changes in fatigue, depression and 
walking ability in the exercise training condition, indicating the role of training adaptation for 
improving outcomes in MS.  
Based on the available literature [7, 21, 30, 31], there are few randomized controlled 
trials that concurrently considered ‘fatigue’ and ‘depression’ as primary endpoints of exercise 
training in persons with MS. Our results confirm previous studies that report beneficial effects of 
exercise training for improving fatigue and depression in persons with MS [11, 31]. Indeed, a 
previous meta-analyses [2, 7, 31] reported that exercise training has small to moderate effects on 
fatigue and depression (the overall weighted mean effect size < -0.50), whereas in the present 
study the effect size estimated by ηp2 for the two-factor ANOVA test (ηp2>0.14) indicated a 
large effect of exercise training on fatigue and depression. This may be explained by our focus 
on fatigue and depression as primary rather that secondary, exploratory end-points. 
Previous studies that were part of a Meta-analyzes did not consider participants' weight 
status. These studies used different exercise types to estimate the effect size of exercise and did 
not distinguish between exercise types. In the present study, we used moderate-intensity (60-75% 
Wpeak) interval exercise. Strong evidence suggests that interval training exercise has a wide range 
of beneficial effects. These effects include increasing both anaerobic and aerobic capacity[25, 
32], delaying the onset of fatigue[25], improving skeletal muscle function[33],  improving 
psychological indicators [34], and decreasing cardiovascular risk[32, 33]. However, most MS 
studies [2, 7, 21, 31] have used resistance, endurance and aquatic exercise as interventions, and 
as a result, the effects of interval exercise has received less attention [25]. We provide novel 
evidence that interval type training can be beneficial for fatigue and depression in persons with 
MS. 
There are several possible moderators that may influence the effects of exercise on the 
symptoms of fatigue and depression. Inactive lifestyles and deconditioning are common among 
persons with MS, and this contributes to weight gain and subsequently, has a negative effect on 
the symptoms of fatigue and depression [2]. We observed that exercise is beneficial in persons 
with MS, but BMI was not a moderator of the changes in fatigue and depression with exercise 
training.  That is, beneficial changes in fatigue and depression were observed after the exercise 
program in both overweight and normal weight groups. We did not identify any significant 
weight loss or BMI changes with exercise training. However, by continuing the exercise program 
(for long-term periods), it may be possible to achieve significant weight loss [35], positively 
affecting fatigue and depression over longer periods of time. Therefore, considering the 
beneficial effects of weight loss based on previous evidence[17, 18], it is recommended 
performing further studies on the effect of weight loss strategies (i.e., long-term exercise 
program) on fatigue and depression. It has been demonstrated previously that weight loss can be 
associated with an increase in 25-hydroxyvitamin D levels, the main circulating vitamin D 
metabolite [12], and since the level of 25-hydroxyvitamin D is associated with depression [36]; it 
seems possible that via this pathway, weight loss can have a positive effect on depression during 
exercise. Additionally, weight loss is associated with a reduction in adipokines, in particular 
leptin [12]. Leptin  is closely related to the symptoms of MS, therefore weight loss will result in 
a decrease in leptin and potentially improvement in the fatigue profile following exercise training 
[25]. 
Numerous primary and secondary pathophysiological pathways have been mentioned that 
underline the symptoms of fatigue and depression associated with MS [7, 37]. We propose here a 
potential mechanism by which exercise can alleviate fatigue and depression in MS through 
improvement in aerobic fitness. Although, we did not observe any interactive effects of exercise 
and weight status for changes in fitness levels (elevated by Vo2peak and TUG) in the current 
study, the exercise group main effect was encouraging. A meta-analysis of 4 studies reported 
non-significant effects of exercise on the TUG test (mean difference = -1.5 sec, 95% CI = 2.19-
0.9) [38].  The meta-analysis also reported a positive effect of exercise on other walking ability 
tests including walking endurance (i.e., 10-m walk test) and speed (i.e., 2- and 6-minute walk 
test) [38]. It is frequently stated in the literature that walking performance is impaired in person 
with MS which is commonly assessed using either 10-m walk test, 6-minute walk test and TUG 
test [38, 39]. TUG reflects walking agility (mobility) which requires several prerequisites for 
improvement such as enhancement in aerobic capacity and muscle strength [39]. Exercise can 
have positive outcomes for walking performance in MS via increases in aerobic capacity and 
muscular strength, indicators that are normally weaker in person with MS when compared to 
healthy individuals [25, 39, 40]. Correlation analysis supported this statement and there were 
moderate correlations observed between improvements in fitness levels and walking 
performance gain. Although a previous systematic and meta-analysis review suggests a 
beneficial role of exercise on walking performance [38, 39], it seems that the evidence is not 
clear and that further studies are needed for clarification. Interestingly, correlational analysis 
suggested a negative correlation between fitness improvement, fatigue and depression. This 
suggests that individuals who observed the greatest fitness improvements also had positive 
changes in fatigue and depression. Therefore, improvement in fitness levels can be considered as 
a beneficial target for person with MS [41]. The findings of this study suggest that this appears to 
be independent of weight status, and is positively associated with improvements in psychological 
indicators (i.e., fatigue and depression). 
The current study has some limitations. Firstly, we did not observe significant changes in 
weight and BMI that could have had an impact on our results. Although BMI was used as a 
moderating factor and an indicator of body composition in the current study, the lack of weight 
loss cannot be attributed entirely to the lack of fat loss.  During the training program, decreasing 
fat tissue and increasing muscle tissue may occur simultaneously, therefore, no significant 
change in weight status was observed. Secondly, BMI is one of the most widely used indexes of 
body composition in MS studies [12, 13, 16, 25], but it has a lower accuracy than methods such 
as dual X-ray absorptiometry (DEXA). Therefore using DEXA in future studies would increase 
internal validity. Thirdly, our intervention included 8-weeks of interval exercise. The short 
duration of the exercise program may be one of the reasons for a non-significant change in 
weight status. Using longer-term durations of exercise may provide more conclusive and 
complementary results. Moreover, the current study did not have a long term follow up which 
could indicate a lasting effect of exercise. Finally, regarding the nature of the current study, the 
small sample size makes interpretations of these data less accurate. In fact, although based on a 
two-factor ANOVA design and anticipated statistical power of 0.8 with an effect size 0.5 and 
alpha error 0.05, at least 15 subjects were necessary (G power program 3.0.10, Germany). 
However, the sample size used in the current study especially in the control groups were small; 
therefore, further studies should be conducted to investigate further the results presented here.  
 
CONCLUSION  
Overall, exercise was efficacious in improving MS-related psychological symptoms, but body 
weight was not a moderating factor related to the exercise induced changes observed. There were 
positive correlations found between changes in Vo2peak and improvements in symptoms of 
fatigue and depression. These findings outlined the important role of exercise-related adaptations 
for improvement in psychological symptoms (i.e., fatigue and depression) in MS patients. It can 
be concluded therefore, that the findings from this study indicate, that improvements in fitness 
levels positively affect psychological parameters in people with MS. These positive outcomes 
can be achieved by exercise without changes in bodyweight 
 
Acknowledgments 
Authors would like to thank all persons with multiple sclerosis for participating in current 
study and all persons who helped us to do current study. 
 Conflict of Interest 
Mostafa Khodadust received support from Abadan Islamic Azad University, Abadan, 
Iran to perform current study. Other authors report no disclosures. 
 
References 
[1] R.A. Marrie, J. Cohen, O. Stuve, M. Trojano, P.S. Sørensen, S. Reingold, G. Cutter, N. Reider, A 
systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview, 
Multiple Sclerosis Journal, 21 (2015) 263-281. 
[2] L.A. Pilutti, T.A. Greenlee, R.W. Motl, M.S. Nickrent, S.J. Petruzzello, Effects of exercise training on 
fatigue in multiple sclerosis: a meta-analysis, Psychosomatic medicine, 75 (2013) 575-580. 
[3] B. Wood, I. Van Der Mei, A.-L. Ponsonby, F. Pittas, S. Quinn, T. Dwyer, R. Lucas, B. Taylor, Prevalence 
and concurrence of anxiety, depression and fatigue over time in multiple sclerosis, Multiple Sclerosis 
Journal, 19 (2013) 217-224. 
[4] S.L. Minden, A. Feinstein, R.C. Kalb, D. Miller, D.C. Mohr, S.B. Patten, C. Bever, R.B. Schiffer, G.S. 
Gronseth, P. Narayanaswami, Evidence-based guideline: assessment and management of psychiatric 
disorders in individuals with MS Report of the Guideline Development Subcommittee of the American 
Academy of Neurology, Neurology, 82 (2014) 174-181. 
[5] R.E. Boeschoten, A.M. Braamse, A.T. Beekman, P. Cuijpers, P. van Oppen, J. Dekker, B.M. Uitdehaag, 
Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis, 
Journal of the neurological sciences, 372 (2017) 331-341. 
[6] A. Malekzadeh, W. Van de Geer-Peeters, V. De Groot, C. Elisabeth Teunissen, H. Beckerman, Fatigue 
in patients with multiple sclerosis: is it related to pro-and anti-inflammatory cytokines?, Disease 
markers, 2015 (2015). 
[7] I. Ensari, R.W. Motl, L.A. Pilutti, Exercise training improves depressive symptoms in people with 
multiple sclerosis: results of a meta-analysis, Journal of psychosomatic research, 76 (2014) 465-471. 
[8] R.W. Motl, J. Gosney, Effect of exercise training on quality of life in multiple sclerosis: a meta-
analysis, Multiple Sclerosis Journal, 14 (2008) 129-135. 
[9] R.W. Motl, E. McAuley, E.M. Snook, R.C. Gliottoni, Physical activity and quality of life in multiple 
sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support, 
Psychology, health & medicine, 14 (2009) 111-124. 
[10] D. Lee, R. Newell, L. Ziegler, A. Topping, Treatment of fatigue in multiple sclerosis: a systematic 
review of the literature, International journal of nursing practice, 14 (2008) 81-93. 
[11] R.W. Motl, B.M. Sandroff, G. Kwakkel, U. Dalgas, A. Feinstein, C. Heesen, P. Feys, A.J. Thompson, 
Exercise in patients with multiple sclerosis, The Lancet Neurology, 16 (2017) 848-856. 
[12] K.L. Munger, J. Bentzen, B. Laursen, E. Stenager, N. Koch-Henriksen, T.I. Sørensen, J.L. Baker, 
Childhood body mass index and multiple sclerosis risk: a long-term cohort study, Multiple Sclerosis 
Journal, 19 (2013) 1323-1329. 
[13] S.R. Khurana, A.M. Bamer, A.P. Turner, R.V. Wadhwani, J.D. Bowen, S.L. Leipertz, J.K. Haselkorn, The 
prevalence of overweight and obesity in veterans with multiple sclerosis, American journal of physical 
medicine & rehabilitation, 88 (2009) 83-91. 
[14] J. Freeman, J. Hobart, D. Langdon, A. Thompson, Clinical appropriateness: a key factor in outcome 
measure selection: the 36 item short form health survey in multiple sclerosis, Journal of Neurology, 
Neurosurgery & Psychiatry, 68 (2000) 150-156. 
[15] A.N. Vgontzas, E.O. Bixler, G.P. Chrousos, Obesity‐related sleepiness and fatigue, Annals of the New 
York Academy of Sciences, 1083 (2006) 329-344. 
[16] A. Kalron, Relationship of obesity with gait and balance in people with multiple sclerosis, American 
journal of physical medicine & rehabilitation, 96 (2017) 140-145. 
[17] O.S. Gondim, V.T.N. de Camargo, F.A. Gutierrez, P.F. de Oliveira Martins, M.E.P. Passos, C.M. 
Momesso, V.C. Santos, R. Gorjão, T.C. Pithon-Curi, M.F. Cury-Boaventura, Benefits of regular exercise on 
inflammatory and cardiovascular risk markers in normal weight, overweight and obese adults, PLoS One, 
10 (2015) e0140596. 
[18] P. Ekkekakis, E. Lind, S. Vazou, Affective responses to increasing levels of exercise intensity in 
normal‐weight, overweight, and obese middle‐aged women, Obesity, 18 (2010) 79-85. 
[19] C.H. Polman, S.C. Reingold, B. Banwell, M. Clanet, J.A. Cohen, M. Filippi, K. Fujihara, E. Havrdova, M. 
Hutchinson, L. Kappos, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, 
Annals of neurology, 69 (2011) 292-302. 
[20] M. Azimian, A. Shahvarughi Farahani, A. Dadkhah, M. Fallahpour, M. Karimlu, Fatigue severity scale: 
the psychometric properties of the Persian-version in patients with multiple sclerosis, Research Journal 
of Biological Sciences, 4 (2009) 974-977. 
[21] M.P. Herring, K.M. Fleming, S.P. Hayes, R.W. Motl, S.B. Coote, Moderators of Exercise Effects on 
Depressive Symptoms in Multiple Sclerosis: A Meta-regression, American Journal of Preventive 
Medicine, (2017). 
[22] H. Ghassemzadeh, R. Mojtabai, N. Karamghadiri, N. Ebrahimkhani, Psychometric properties of a 
Persian‐language version of the Beck Depression Inventory‐Second edition: BDI‐II‐PERSIAN, Depression 
and anxiety, 21 (2005) 185-192. 
[23] Y. Nilsagard, C. Lundholm, L.G. Gunnarsson, E. Denison, Clinical relevance using timed walk tests 
and ‘timed up and go’testing in persons with multiple sclerosis, Physiotherapy Research International, 
12 (2007) 105-114. 
[24] N. Majdinasab, R.W. Motl, M. Mokhtarzade, P. Zimmer, R. Ranjbar, C. Keytsman, T. Cullen, R. 
Negaresh, J.S. Baker, Acute responses of cytokines and adipokines to aerobic exercise in relapsing vs. 
remitting women with multiple sclerosis, Complementary Therapies in Clinical Practice, (2018). 
[25] M. Mokhtarzade, R. Ranjbar, N. Majdinasab, D. Patel, M.M. Shamsi, Effect of aerobic interval 
training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations 
with fatigue and quality of life, Endocrine, (2017) 1-10. 
[26] A.E. Tjønna, T.O. Stølen, A. Bye, M. Volden, S.A. Slørdahl, R. Ødegård, E. Skogvoll, U. Wisløff, Aerobic 
interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight 
adolescents, Clinical science, 116 (2009) 317-326. 
[27] S. Keating, N. Johnson, G. Mielke, J. Coombes, A systematic review and meta‐analysis of interval 
training versus moderate‐intensity continuous training on body adiposity, Obesity Reviews, 18 (2017) 
943-964. 
[28] T.W. Storer, J.A. Davis, V.J. Caiozzo, Accurate prediction of VO2max in cycle ergometry, Medicine 
and Science in Sports and Exercise, 22 (1990) 704-712. 
[29] M.N. Sawka, M.E. Foley, N.A. Pimental, M.M. Toner, K.B. Pandolf, Determination of maximal aerobic 
power during upper-body exercise, Journal of applied Physiology, 54 (1983) 113-117. 
[30] A. Andreasen, E. Stenager, U. Dalgas, The effect of exercise therapy on fatigue in multiple sclerosis, 
Multiple Sclerosis Journal, 17 (2011) 1041-1054. 
[31] U. Dalgas, E. Stenager, M. Sloth, The effect of exercise on depressive symptoms in multiple sclerosis 
based on a meta‐analysis and critical review of the literature, European journal of neurology, 22 (2015) 
443. 
[32] P. Zimmer, W. Bloch, A. Schenk, M. Oberste, S. Riedel, J. Kool, D. Langdon, U. Dalgas, J. Kesselring, J. 
Bansi, High-intensity interval exercise improves cognitive performance and reduces matrix 
metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial, 
Multiple Sclerosis Journal, (2017) 1352458517728342. 
[33] S.A. Costigan, N. Eather, R. Plotnikoff, D.R. Taaffe, D.R. Lubans, High-intensity interval training for 
improving health-related fitness in adolescents: a systematic review and meta-analysis, Br J Sports Med, 
(2015) bjsports-2014-094490. 
[34] M.J. Stork, L.E. Banfield, M.J. Gibala, K.A. Martin Ginis, A scoping review of the psychological 
responses to interval exercise: Is interval exercise a viable alternative to traditional exercise?, Health 
psychology review, 11 (2017) 324-344. 
[35] D.L. Swift, N.M. Johannsen, C.J. Lavie, C.P. Earnest, T.S. Church, The role of exercise and physical 
activity in weight loss and maintenance, Progress in cardiovascular diseases, 56 (2014) 441-447. 
[36] S. Knippenberg, Y. Bol, J. Damoiseaux, R. Hupperts, J. Smolders, Vitamin D status in patients with 
MS is negatively correlated with depression, but not with fatigue, Acta Neurologica Scandinavica, 124 
(2011) 171-175. 
[37] M. Langeskov-Christensen, E.J. Bisson, M.L. Finlayson, U. Dalgas, Potential pathophysiological 
pathways that can explain the positive effects of exercise on fatigue in multiple sclerosis: A scoping 
review, Journal of the Neurological Sciences, (2017). 
[38] M. Pearson, G. Dieberg, N. Smart, Exercise as a therapy for improvement of walking ability in adults 
with multiple sclerosis: a meta-analysis, Archives of physical medicine and rehabilitation, 96 (2015) 
1339-1348. e1337. 
[39] A.E. Latimer-Cheung, L.A. Pilutti, A.L. Hicks, K.A.M. Ginis, A.M. Fenuta, K.A. MacKibbon, R.W. Motl, 
Effects of exercise training on fitness, mobility, fatigue, and health-related quality of life among adults 
with multiple sclerosis: a systematic review to inform guideline development, Archives of physical 
medicine and rehabilitation, 94 (2013) 1800-1828. e1803. 
[40] R.W. Motl, L.A. Pilutti, The benefits of exercise training in multiple sclerosis, Nature Reviews 
Neurology, 8 (2012) 487-497. 
[41] E. Sebastião, E. Hubbard, R. Klaren, L. Pilutti, R. Motl, Fitness and its association with fatigue in 
persons with multiple sclerosis, Scandinavian journal of medicine & science in sports, 27 (2017) 1776-
1784. 
 
 
